Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Fernandez (München, Germany), F. Greiffo (München, Germany), R. Roi (Perth, Australia), J. Behr (München, Germany), A. Forrest (Perth, United States of America), O. Eickelberg (München, Germany). Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks. 4926

Member's Comments

No comment yet.

Related content which might interest you: Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 PRRX1 a pro-fibrotic mesenchymal transcription factor modulated by remodeled microenvironment in IPF Source: ERS Lung Science Conference 2018 Year: 2018 Circulating fibrocytes depletion results in reduced lung tumor growth and metastasis by modulating macrophage phenotype, angiogenesis and endothelin system Source: ERS Lung Science Conference 2017 Year: 2017 Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018 Year: 2018 Evidence for differential roles of Th1 and Th17 cytokines in the pathogenesis of COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Arginine levels regulate pro-inflammatory mediator responses by lung epithelial cells Source: Eur Respir J 2005; 26: Suppl. 49, 554s Year: 2005 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Inflammatory microenvironment in both healthy controls and ARDS patients polarize clinically utilized MSCs towards a pro-inflammatory MSC phenotype Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Tim-3 regulates Tregs’ ability to resolve the inflammation and proliferation of acute lung injury by polarizing M2c macrophages Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Inflammation regulating cytokines in TB affected tissues. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 GM-CSF and CSF-1 co-regulate lung inflammation and ERMP12+ progenitor recruitment during immune responses to LPS in vivo Source: Eur Respir J 2006; 28: Suppl. 50, 300s Year: 2006 The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003 Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process Source: Eur Respir J 2004; 24: Suppl. 48, 592s Year: 2004 Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Identification of an IL-6-dependent macrophage population required for driving fibrotic disease Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 NTHi-induced inflammation activates the PD-1 immune checkpoint in the tumor microenvironment Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018